Osilodrostat: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Osilodrostat. Educational only — not medical advice.

Labeled uses

ISTURISA is indicated for the treatment of endogenous hypercortisolemia in adults with Cushing's syndrome for whom surgery is not an option or has not been curative.

Source: FDA labeling via NIH DailyMed (set f3a5ec24…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.

Ratings summarize government-reported measures — they don't capture your personal needs. Visit the facility, ask about staffing and services, and use CMS checklists. This profile is informational only and is not a recommendation.